<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32560258</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Multiple Roles of Transforming Growth Factor Beta in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4291</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21124291</ELocationID><Abstract><AbstractText>Transforming growth factor beta (TGFB) is a pleiotropic cytokine known to be dysregulated in many neurodegenerative disorders and particularly in amyotrophic lateral sclerosis (ALS). This motor neuronal disease is non-cell autonomous, as it affects not only motor neurons but also the surrounding glial cells, and the target skeletal muscle fibers. Here, we analyze the multiple roles of TGFB in these cell types, and how TGFB signaling is altered in ALS tissues. Data reported support a crucial involvement of TGFB in the etiology and progression of ALS, leading us to hypothesize that an imbalance of TGFB signaling, diminished at the pre-symptomatic stage and then increased with time, could be linked to ALS progression. A reduced stimulation of the TGFB pathway at the beginning of disease blocks its neuroprotective effects and promotes glutamate excitotoxicity. At later disease stages, the persistent activation of the TGFB pathway promotes an excessive microglial activation and strengthens muscular dysfunction. The therapeutic potential of TGFB is discussed, in order to foster new approaches to treat ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Galbiati</LastName><ForeName>Mariarita</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3250-5591</Identifier><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro di Eccellenza sulle Malattie Neurodegenerative, Universit&#xe0; degli Studi di Milano, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crippa</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro di Eccellenza sulle Malattie Neurodegenerative, Universit&#xe0; degli Studi di Milano, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusmini</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9989-0733</Identifier><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro di Eccellenza sulle Malattie Neurodegenerative, Universit&#xe0; degli Studi di Milano, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cristofani</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2719-846X</Identifier><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro di Eccellenza sulle Malattie Neurodegenerative, Universit&#xe0; degli Studi di Milano, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messi</LastName><ForeName>Elio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro di Eccellenza sulle Malattie Neurodegenerative, Universit&#xe0; degli Studi di Milano, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piccolella</LastName><ForeName>Margherita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro di Eccellenza sulle Malattie Neurodegenerative, Universit&#xe0; degli Studi di Milano, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedesco</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro di Eccellenza sulle Malattie Neurodegenerative, Universit&#xe0; degli Studi di Milano, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro di Eccellenza sulle Malattie Neurodegenerative, Universit&#xe0; degli Studi di Milano, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casarotto</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro di Eccellenza sulle Malattie Neurodegenerative, Universit&#xe0; degli Studi di Milano, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chierichetti</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro di Eccellenza sulle Malattie Neurodegenerative, Universit&#xe0; degli Studi di Milano, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poletti</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8883-0468</Identifier><AffiliationInfo><Affiliation>Dipartimento di Scienze Farmacologiche e Biomolecolari, Centro di Eccellenza sulle Malattie Neurodegenerative, Universit&#xe0; degli Studi di Milano, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GGP14039</GrantID><Agency>Fondazione Telethon</Agency><Country/></Grant><Grant><GrantID>GGP19128</GrantID><Agency>Fondazione Telethon</Agency><Country/></Grant><Grant><GrantID>2018 grant</GrantID><Agency>Kennedy's Disease Association</Agency><Country/></Grant><Grant><GrantID>2014-0686</GrantID><Agency>Fondazione Cariplo</Agency><Country/></Grant><Grant><GrantID>2017-0747</GrantID><Agency>Fondazione Cariplo</Agency><Country/></Grant><Grant><GrantID>ALS_HSPB8</GrantID><Agency>Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica</Agency><Country/></Grant><Grant><GrantID>ALS_Granulopathy</GrantID><Agency>Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica</Agency><Country/></Grant><Grant><GrantID>Target_RAN</GrantID><Agency>Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica</Agency><Country/></Grant><Grant><GrantID>16406</GrantID><Agency>Association Fran&#xe7;aise contre les Myopathies</Agency><Country/></Grant><Grant><GrantID>Piano di sviluppo UNIMI - linea B</GrantID><Agency>Universit&#xe0; degli Studi di Milano</Agency><Country/></Grant><Grant><GrantID>Bando SEED 2019: #TDP-43-iPSC</GrantID><Agency>Universit&#xe0; degli Studi di Milano</Agency><Country/></Grant><Grant><GrantID>PRIN 2015LFPNMN</GrantID><Agency>Ministero dell'Istruzione, dell'Universit&#xe0; e della Ricerca</Agency><Country/></Grant><Grant><GrantID>2018</GrantID><Agency>Fondo per il Finanziamento delle Attivit&#xe0; Base di Ricerca</Agency><Country/></Grant><Grant><GrantID>Co_ALS</GrantID><Agency>Agenzia Italiana del Farmaco, Ministero della Salute</Agency><Country/></Grant><Grant><GrantID>TRANS_ALS</GrantID><Agency>Fondazione Regionale per la Ricerca Biomedica</Agency><Country/></Grant><Grant><GrantID>01ED1601A, CureALS</GrantID><Agency>EU Joint Programme - Neurodegenerative Disease Research</Agency><Country/></Grant><Grant><GrantID>Progetto Dipartimenti di Eccellenza</GrantID><Agency>Ministero dell'Istruzione, dell'Universit&#xe0; e della Ricerca</Agency><Country/></Grant><Grant><GrantID>PRIN 2017F2AC5</GrantID><Agency>Ministero dell'Istruzione, dell'Universit&#xe0; e della Ricerca</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>3KX376GY7L</RegistryNumber><NameOfSubstance UI="D018698">Glutamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018698" MajorTopicYN="N">Glutamic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018485" MajorTopicYN="N">Muscle Fibers, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">TGFB</Keyword><Keyword MajorTopicYN="N">glial cells</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword><Keyword MajorTopicYN="N">skeletal muscle</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32560258</ArticleId><ArticleId IdType="pmc">PMC7352289</ArticleId><ArticleId IdType="doi">10.3390/ijms21124291</ArticleId><ArticleId IdType="pii">ijms21124291</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marin B., Boumediene F., Logroscino G., Couratier P., Babron M.C., Leutenegger A.L., Copetti M., Preux P.M., Beghi E. Variation in worldwide incidence of amyotrophic lateral sclerosis: A meta-analysis. Int. J. Epidemiol. 2017;46:57&#x2013;74. doi: 10.1093/ije/dyw061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw061</ArticleId><ArticleId IdType="pmc">PMC5407171</ArticleId><ArticleId IdType="pubmed">27185810</ArticleId></ArticleIdList></Reference><Reference><Citation>Vegeto E., Villa A., Della Torre S., Crippa V., Rusmini P., Cristofani R., Galbiati M., Maggi A., Poletti A. The Role of sex and sex hormones in neurodegenerative diseases. Endocr. Rev. 2020;41:273&#x2013;319. doi: 10.1210/endrev/bnz005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endrev/bnz005</ArticleId><ArticleId IdType="pmc">PMC7156855</ArticleId><ArticleId IdType="pubmed">31544208</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E., Bieniek K.F., Gendron T.F., Caulfield T., Lin W.L., Dejesus-Hernandez M., van Blitterswijk M.M., Jansen-West K., Paul J.W., III, Rademakers R., et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013;77:639&#x2013;646. doi: 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashley T., Hardy J., Isaacs A.M. RANTing about C9orf72. Neuron. 2013;77:597&#x2013;598. doi: 10.1016/j.neuron.2013.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.009</ArticleId><ArticleId IdType="pubmed">23439112</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Weng S.M., Arzberger T., May S., Rentzsch K., Kremmer E., Schmid B., Kretzschmar H.A., Cruts M., Van Broeckhoven C., et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339:1335&#x2013;1338. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S., Vande Velde C., Cleveland D.W. ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52:39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A.M., Hester M.E., Miranda C.J., Meyer K., Braun L., Frakes A., Song S., Likhite S., Murtha M.J., Foust K.D., et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 2011;29:824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302:113&#x2013;117. doi: 10.1126/science.1086071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Komine O. The multi-dimensional roles of astrocytes in ALS. Neurosci. Res. 2018;126:31&#x2013;38. doi: 10.1016/j.neures.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.09.011</ArticleId><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Yamashita H. [ALS and microglia--a player for non-cell-autonomous neuron death] Brain Nerve = Shinkei Kenkyu Shinpo. 2007;59:1163&#x2013;1170.</Citation><ArticleIdList><ArticleId IdType="pubmed">17969357</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo F., Komine O., Fujimori-Tonou N., Katsuno M., Jin S., Watanabe S., Sobue G., Dezawa M., Wyss-Coray T., Yamanaka K. Astrocyte-derived TGF-beta1 accelerates disease progression in ALS mice by interfering with the neuroprotective functions of microglia and T cells. Cell Rep. 2015;11:592&#x2013;604. doi: 10.1016/j.celrep.2015.03.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.03.053</ArticleId><ArticleId IdType="pubmed">25892237</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Higginbottom A., Heath P.R., Barber S., Greenald D., Kirby J., Shaw P.J. Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain. 2011;134:2627&#x2013;2641. doi: 10.1093/brain/awr193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr193</ArticleId><ArticleId IdType="pmc">PMC3170534</ArticleId><ArticleId IdType="pubmed">21908873</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenblum L.T., Trotti D. EAAT2 and the molecular signature of amyotrophic lateral sclerosis. Adv. Neurobiol. 2017;16:117&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6668619</ArticleId><ArticleId IdType="pubmed">28828608</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexianu M.E., Kozovska M., Appel S.H. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology. 2001;57:1282&#x2013;1289. doi: 10.1212/WNL.57.7.1282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.57.7.1282</ArticleId><ArticleId IdType="pubmed">11591849</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Hao W., Dawson A., Liu S., Fassbender K. Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2. J. Biol. Chem. 2009;284:3691&#x2013;3699. doi: 10.1074/jbc.M804446200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M804446200</ArticleId><ArticleId IdType="pubmed">19091752</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber Y.N., Sabourin J.C., Rabano M., Vivanco M., Perrin F.E. Early functional deficit and microglial disturbances in a mouse model of amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e36000. doi: 10.1371/journal.pone.0036000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0036000</ArticleId><ArticleId IdType="pmc">PMC3338492</ArticleId><ArticleId IdType="pubmed">22558300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonneman A., Robberecht W., Van Den Bosch L. The role of oligodendroglial dysfunction in amyotrophic lateral sclerosis. Neurodegener. Dis. Manag. 2014;4:223&#x2013;239. doi: 10.2217/nmt.14.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt.14.21</ArticleId><ArticleId IdType="pubmed">25095817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Meyer K., Sherwood T.W., Vick J., Likhite S., Frakes A., Miranda C.J., Braun L., Heath P.R., Pineda R., et al. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism. Proc. Natl. Acad. Sci. USA. 2016;113:E6496&#x2013;E6505. doi: 10.1073/pnas.1607496113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607496113</ArticleId><ArticleId IdType="pmc">PMC5081600</ArticleId><ArticleId IdType="pubmed">27688759</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Aucello M., Rizzuto E., Beccafico S., Mammucari C., Boncompagni S., Belia S., Wannenes F., Nicoletti C., Del Prete Z., et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 2008;8:425&#x2013;436. doi: 10.1016/j.cmet.2008.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.09.002</ArticleId><ArticleId IdType="pubmed">19046573</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Giacinti C., Pelosi L., Nicoletti C., Winn N., Barberi L., Molinaro M., Rosenthal N., Musaro A. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J. Cell Biol. 2005;168:193&#x2013;199. doi: 10.1083/jcb.200407021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200407021</ArticleId><ArticleId IdType="pmc">PMC2171577</ArticleId><ArticleId IdType="pubmed">15657392</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M., Martin L.J. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 2010;19:2284&#x2013;2302. doi: 10.1093/hmg/ddq106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq106</ArticleId><ArticleId IdType="pmc">PMC2865380</ArticleId><ArticleId IdType="pubmed">20223753</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano R., Toivonen J.M., Olivan S., Calvo A.C., Moreno-Igoa M., Munoz M.J., Zaragoza P., Garcia-Redondo A., Osta R. Altered expression of myogenic regulatory factors in the mouse model of amyotrophic lateral sclerosis. Neurodegener. Dis. 2011;8:386&#x2013;396. doi: 10.1159/000324159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000324159</ArticleId><ArticleId IdType="pubmed">21346327</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P.F., Barani A., Wanschitz J., Dubourg O., Lombes A., Bigot A., Mouly V., Bruneteau G., Salachas F., Lenglet T., et al. Abnormalities of satellite cells function in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2011;12:264&#x2013;271. doi: 10.3109/17482968.2011.566618.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.566618</ArticleId><ArticleId IdType="pubmed">21473708</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V., Boncoraglio A., Galbiati M., Aggarwal T., Rusmini P., Giorgetti E., Cristofani R., Carra S., Pennuto M., Poletti A. Differential autophagy power in the spinal cord and muscle of transgenic ALS mice. Front. Cell. Neurosci. 2013;7:234. doi: 10.3389/fncel.2013.00234.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00234</ArticleId><ArticleId IdType="pmc">PMC3840302</ArticleId><ArticleId IdType="pubmed">24324403</ArticleId></ArticleIdList></Reference><Reference><Citation>Galbiati M., Onesto E., Zito A., Crippa V., Rusmini P., Mariotti R., Bentivoglio M., Bendotti C., Poletti A. The anabolic/androgenic steroid nandrolone exacerbates gene expression modifications induced by mutant SOD1 in muscles of mice models of amyotrophic lateral sclerosis. Pharmacol. Res. 2012;65:221&#x2013;230. doi: 10.1016/j.phrs.2011.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2011.12.001</ArticleId><ArticleId IdType="pmc">PMC3272141</ArticleId><ArticleId IdType="pubmed">22178654</ArticleId></ArticleIdList></Reference><Reference><Citation>Meroni M., Crippa V., Cristofani R., Rusmini P., Cicardi M.E., Messi E., Piccolella M., Tedesco B., Ferrari V., Soraru G., et al. Transforming growth factor beta 1 signaling is altered in the spinal cord and muscle of amyotrophic lateral sclerosis mice and patients. Neurobiol. Aging. 2019;82:48&#x2013;59. doi: 10.1016/j.neurobiolaging.2019.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.07.001</ArticleId><ArticleId IdType="pubmed">31394426</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez Lain A., Millecamps S., Dubourg O., Salachas F., Bruneteau G., Lacomblez L., LeGuern E., Seilhean D., Duyckaerts C., Meininger V., et al. Abnormal TDP-43 and FUS proteins in muscles of sporadic IBM: Similarities in a TARDBP-linked ALS patient. J. Neurol. Neurosurg. Psychiatry. 2011;82:1414&#x2013;1416. doi: 10.1136/jnnp.2010.208868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.208868</ArticleId><ArticleId IdType="pubmed">20562395</ArticleId></ArticleIdList></Reference><Reference><Citation>Soraru G., Orsetti V., Buratti E., Baralle F., Cima V., Volpe M., D&#x2019;Ascenzo C., Palmieri A., Koutsikos K., Pegoraro E., et al. TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2010;11:240&#x2013;243. doi: 10.3109/17482960902810890.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902810890</ArticleId><ArticleId IdType="pubmed">19306141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski M.D., Dickson D.W., Powell S.Z., Arumanayagam A.S., Rivera A.L., Appel S.H. Dipeptide repeat (DPR) pathology in the skeletal muscle of ALS patients with C9ORF72 repeat expansion. Acta Neuropathol. 2019;138:667&#x2013;670. doi: 10.1007/s00401-019-02050-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02050-8</ArticleId><ArticleId IdType="pmc">PMC6778061</ArticleId><ArticleId IdType="pubmed">31375896</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi M.E., Cristofani R., Rusmini P., Meroni M., Ferrari V., Vezzoli G., Tedesco B., Piccolella M., Messi E., Galbiati M., et al. Tdp-25 Routing to autophagy and proteasome ameliorates its aggregation in amyotrophic lateral sclerosis target cells. Sci. Rep. 2018;8:12390. doi: 10.1038/s41598-018-29658-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-29658-2</ArticleId><ArticleId IdType="pmc">PMC6098007</ArticleId><ArticleId IdType="pubmed">30120266</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V., Galbiati M., Boncoraglio A., Rusmini P., Onesto E., Giorgetti E., Cristofani R., Zito A., Poletti A. Motoneuronal and muscle-selective removal of ALS-related misfolded proteins. Biochem. Soc. Trans. 2013;41:1598&#x2013;1604. doi: 10.1042/BST20130118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20130118</ArticleId><ArticleId IdType="pubmed">24256261</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E., Rusmini P., Crippa V., Ferri N., Zito A., Galbiati M., Poletti A. Muscle cells and motoneurons differentially remove mutant SOD1 causing familial amyotrophic lateral sclerosis. J. Neurochem. 2011;118:266&#x2013;280. doi: 10.1111/j.1471-4159.2011.07298.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07298.x</ArticleId><ArticleId IdType="pmc">PMC3206220</ArticleId><ArticleId IdType="pubmed">21554318</ArticleId></ArticleIdList></Reference><Reference><Citation>Massague J. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 2000;1:169&#x2013;178. doi: 10.1038/35043051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35043051</ArticleId><ArticleId IdType="pubmed">11252892</ArticleId></ArticleIdList></Reference><Reference><Citation>David C.J., Massague J. Contextual determinants of TGFbeta action in development, immunity and cancer. Nat. Rev. Mol. Cell Biol. 2018;19:419&#x2013;435. doi: 10.1038/s41580-018-0007-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-018-0007-0</ArticleId><ArticleId IdType="pmc">PMC7457231</ArticleId><ArticleId IdType="pubmed">29643418</ArticleId></ArticleIdList></Reference><Reference><Citation>Massague J., Seoane J., Wotton D. Smad transcription factors. Genes Dev. 2005;19:2783&#x2013;2810. doi: 10.1101/gad.1350705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1350705</ArticleId><ArticleId IdType="pubmed">16322555</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Y., Gudey S.K., Landstrom M. Non-Smad signaling pathways. Cell Tissue Res. 2012;347:11&#x2013;20. doi: 10.1007/s00441-011-1201-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-011-1201-y</ArticleId><ArticleId IdType="pubmed">21701805</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss A., Attisano L. The TGFbeta superfamily signaling pathway. Wiley Interdiscip. Rev. Dev. Biol. 2013;2:47&#x2013;63. doi: 10.1002/wdev.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wdev.86</ArticleId><ArticleId IdType="pubmed">23799630</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzi L., Attisano L. Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation. Oncogene. 2004;23:2071&#x2013;2078. doi: 10.1038/sj.onc.1207412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1207412</ArticleId><ArticleId IdType="pubmed">15021894</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.E. Non-Smad signaling pathways of the TGF-beta family. Cold Spring Harb. Perspect. Biol. 2017;9 doi: 10.1101/cshperspect.a022129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a022129</ArticleId><ArticleId IdType="pmc">PMC5287080</ArticleId><ArticleId IdType="pubmed">27864313</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrigo J., Campos F., Simon F., Riedel C., Cabrera D., Vilos C., Cabello-Verrugio C. TGF-beta requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy. Biol. Chem. 2018;399:253&#x2013;264. doi: 10.1515/hsz-2017-0217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2017-0217</ArticleId><ArticleId IdType="pubmed">29140787</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao C.C., Ala T.A., Hu S., Crossley K.B., Sherman R.E., Peterson P.K., Frey W.H. 2nd, Serum cytokine levels in patients with Alzheimer&#x2019;s disease. Clin. Diagn. Lab. Immunol. 1994;1:433&#x2013;436. doi: 10.1128/CDLI.1.4.433-436.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CDLI.1.4.433-436.1994</ArticleId><ArticleId IdType="pmc">PMC368282</ArticleId><ArticleId IdType="pubmed">8556481</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogi M., Harada M., Kondo T., Narabayashi H., Riederer P., Nagatsu T. Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson&#x2019;s disease. Neurosci. Lett. 1995;193:129&#x2013;132. doi: 10.1016/0304-3940(95)11686-Q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(95)11686-Q</ArticleId><ArticleId IdType="pubmed">7478158</ArticleId></ArticleIdList></Reference><Reference><Citation>Houi K., Kobayashi T., Kato S., Mochio S., Inoue K. Increased plasma TGF-beta1 in patients with amyotrophic lateral sclerosis. Acta Neurol. Scand. 2002;106:299&#x2013;301. doi: 10.1034/j.1600-0404.2002.01301.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0404.2002.01301.x</ArticleId><ArticleId IdType="pubmed">12371924</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilzecka J., Stelmasiak Z., Dobosz B. Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis. Cytokine. 2002;20:239&#x2013;243. doi: 10.1006/cyto.2002.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/cyto.2002.2005</ArticleId><ArticleId IdType="pubmed">12550109</ArticleId></ArticleIdList></Reference><Reference><Citation>Duque T., Gromicho M., Pronto-Laborinho A.C., de Carvalho M. Transforming growth factor-beta plasma levels and its role in amyotrophic lateral sclerosis. Med. Hypotheses. 2020;139:109632. doi: 10.1016/j.mehy.2020.109632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109632</ArticleId><ArticleId IdType="pubmed">32085981</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubiri I., Lombardi V., Bremang M., Mitra V., Nardo G., Adiutori R., Lu C.H., Leoni E., Yip P., Yildiz O., et al. Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis. Mol. Neurodegener. 2018;13:60. doi: 10.1186/s13024-018-0292-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0292-2</ArticleId><ArticleId IdType="pmc">PMC6223075</ArticleId><ArticleId IdType="pubmed">30404656</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda T., Itoh J., Koide T., Tomidokoro Y., Takei Y., Ishii K., Tamaoka A. Transforming growth factor-beta1 in the cerebrospinal fluid of patients with distinct neurodegenerative diseases. J. Clin. Neurosci. 2017;35:47&#x2013;49. doi: 10.1016/j.jocn.2016.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2016.09.018</ArticleId><ArticleId IdType="pubmed">27756506</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida A., Takahashi A., Kubo M., Saito S., Hosono N., Ohnishi Y., Kiyotani K., Mushiroda T., Nakajima M., Ozaki K., et al. A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese. Hum. Mol. Genet. 2011;20:3684&#x2013;3692. doi: 10.1093/hmg/ddr268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr268</ArticleId><ArticleId IdType="pubmed">21665992</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetsuka S., Morita M., Iida A., Uehara R., Ikegawa S., Nakano I. ZNF512B gene is a prognostic factor in patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 2013;324:163&#x2013;166. doi: 10.1016/j.jns.2012.10.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2012.10.029</ArticleId><ArticleId IdType="pubmed">23168171</ArticleId></ArticleIdList></Reference><Reference><Citation>Komuta Y., Teng X., Yanagisawa H., Sango K., Kawamura K., Kawano H. Expression of transforming growth factor-beta receptors in meningeal fibroblasts of the injured mouse brain. Cell. Mol. Neurobiol. 2010;30:101&#x2013;111. doi: 10.1007/s10571-009-9435-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-009-9435-x</ArticleId><ArticleId IdType="pubmed">19653094</ArticleId></ArticleIdList></Reference><Reference><Citation>Unsicker K., Flanders K.C., Cissel D.S., Lafyatis R., Sporn M.B. Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system. Neuroscience. 1991;44:613&#x2013;625. doi: 10.1016/0306-4522(91)90082-Y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-4522(91)90082-Y</ArticleId><ArticleId IdType="pubmed">1754055</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincze C., Pal G., Wappler E.A., Szabo E.R., Nagy Z.G., Lovas G., Dobolyi A. Distribution of mRNAs encoding transforming growth factors-beta1, -2, and -3 in the intact rat brain and after experimentally induced focal ischemia. J. Comp. Neurol. 2010;518:3752&#x2013;3770. doi: 10.1002/cne.22422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.22422</ArticleId><ArticleId IdType="pubmed">20653032</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottner M., Krieglstein K., Unsicker K. The transforming growth factor-betas: Structure, signaling, and roles in nervous system development and functions. J. Neurochem. 2000;75:2227&#x2013;2240. doi: 10.1046/j.1471-4159.2000.0752227.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2000.0752227.x</ArticleId><ArticleId IdType="pubmed">11080174</ArticleId></ArticleIdList></Reference><Reference><Citation>Diniz L.P., Matias I., Siqueira M., Stipursky J., Gomes F.C.A. Astrocytes and the TGF-beta1 Pathway in the Healthy and Diseased Brain: A Double-Edged Sword. Mol. Neurobiol. 2019;56:4653&#x2013;4679. doi: 10.1007/s12035-018-1396-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1396-y</ArticleId><ArticleId IdType="pubmed">30377983</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukushima T., Liu R.Y., Byrne J.H. Transforming growth factor-beta2 modulates synaptic efficacy and plasticity and induces phosphorylation of CREB in hippocampal neurons. Hippocampus. 2007;17:5&#x2013;9. doi: 10.1002/hipo.20243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.20243</ArticleId><ArticleId IdType="pubmed">17094084</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon V.Y., Choi S., Park M. Growth factors in synaptic function. Front. Synaptic Neurosci. 2013;5:6. doi: 10.3389/fnsyn.2013.00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsyn.2013.00006</ArticleId><ArticleId IdType="pmc">PMC3776238</ArticleId><ArticleId IdType="pubmed">24065916</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller M.W. Expression of transforming growth factor-beta in developing rat cerebral cortex: Effects of prenatal exposure to ethanol. J. Comp. Neurol. 2003;460:410&#x2013;424. doi: 10.1002/cne.10658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.10658</ArticleId><ArticleId IdType="pubmed">12692858</ArticleId></ArticleIdList></Reference><Reference><Citation>Siqueira M., Francis D., Gisbert D., Gomes F.C.A., Stipursky J. Radial glia cells control angiogenesis in the developing cerebral cortex through TGF-beta1 signaling. Mol. Neurobiol. 2018;55:3660&#x2013;3675.</Citation><ArticleIdList><ArticleId IdType="pubmed">28523566</ArticleId></ArticleIdList></Reference><Reference><Citation>Koeglsperger T., Li S., Brenneis C., Saulnier J.L., Mayo L., Carrier Y., Selkoe D.J., Weiner H.L. Impaired glutamate recycling and GluN2B-mediated neuronal calcium overload in mice lacking TGF-beta1 in the CNS. Glia. 2013;61:985&#x2013;1002. doi: 10.1002/glia.22490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22490</ArticleId><ArticleId IdType="pmc">PMC3981075</ArticleId><ArticleId IdType="pubmed">23536313</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., McLennan I.S., Koishi K., Hendry I.A. Transforming growth factor-beta 2 is anterogradely and retrogradely transported in motoneurons and up-regulated after nerve injury. Neuroscience. 2000;97:735&#x2013;742. doi: 10.1016/S0306-4522(00)00084-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(00)00084-1</ArticleId><ArticleId IdType="pubmed">10842018</ArticleId></ArticleIdList></Reference><Reference><Citation>Oppenheim R.W., Prevette D., Haverkamp L.J., Houenou L., Yin Q.W., McManaman J. Biological studies of a putative avian muscle-derived neurotrophic factor that prevents naturally occurring motoneuron death In Vivo. J. Neurobiol. 1993;24:1065&#x2013;1079. doi: 10.1002/neu.480240806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/neu.480240806</ArticleId><ArticleId IdType="pubmed">8409968</ArticleId></ArticleIdList></Reference><Reference><Citation>Prehn J.H., Peruche B., Unsicker K., Krieglstein J. Isoform-specific effects of transforming growth factors-beta on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate. J. Neurochem. 1993;60:1665&#x2013;1672. doi: 10.1111/j.1471-4159.1993.tb13389.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1993.tb13389.x</ArticleId><ArticleId IdType="pubmed">8097233</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki Y., Shiojima T., Tagaya N., Kobayashi T., Kinoshita M. Effect of transforming growth factor beta 1 on spinal motor neurons after axotomy. J. Neurol. Sci. 1997;147:9&#x2013;12. doi: 10.1016/S0022-510X(96)05307-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(96)05307-5</ArticleId><ArticleId IdType="pubmed">9094054</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami N., McLennan I.S., Nonaka I., Koishi K., Baker C., Hammond-Tooke G. Transforming growth factor-beta2 is elevated in skeletal muscle disorders. Muscle Nerve. 1999;22:889&#x2013;898. doi: 10.1002/(SICI)1097-4598(199907)22:7&lt;889::AID-MUS12&gt;3.0.CO;2-B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(199907)22:7&lt;889::AID-MUS12&gt;3.0.CO;2-B</ArticleId><ArticleId IdType="pubmed">10398207</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C.O., Venkatachalam K. Motor neurons from ALS patients with mutations in C9ORF72 and SOD1 exhibit distinct transcriptional landscapes. Hum. Mol. Genet. 2019;28:2799&#x2013;2810. doi: 10.1093/hmg/ddz104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz104</ArticleId><ArticleId IdType="pmc">PMC6687950</ArticleId><ArticleId IdType="pubmed">31107959</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura M., Ito H., Wate R., Nakano S., Hirano A., Kusaka H. Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model. Acta Neuropathol. 2008;115:327&#x2013;334. doi: 10.1007/s00401-007-0337-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0337-z</ArticleId><ArticleId IdType="pubmed">18210139</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura M., Kaneko S., Wate R., Asayama S., Nakamura Y., Fujita K., Ito H., Kusaka H. Regionally different immunoreactivity for Smurf2 and pSmad2/3 in TDP-43-positive inclusions of amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 2013;39:144&#x2013;156. doi: 10.1111/j.1365-2990.2012.01270.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2012.01270.x</ArticleId><ArticleId IdType="pubmed">22435645</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C., Wang I.X., Watts J.A., Burdick J.T., Guber R.D., Zhu Z., Bruzel A., Lanman T., Chen K., Schindler A.B., et al. Senataxin mutation reveals how R-Loops Promote transcription by blocking DNA methylation at gene promoters. Mol. Cell. 2018;69:426&#x2013;437 e7. doi: 10.1016/j.molcel.2017.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.12.030</ArticleId><ArticleId IdType="pmc">PMC5815878</ArticleId><ArticleId IdType="pubmed">29395064</ArticleId></ArticleIdList></Reference><Reference><Citation>Henrich-Noack P., Prehn J.H., Krieglstein J. Neuroprotective effects of TGF-beta 1. J. Neural Transm. Suppl. 1994;43:33&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">7884405</ArticleId></ArticleIdList></Reference><Reference><Citation>Phatnani H.P., Guarnieri P., Friedman B.A., Carrasco M.A., Muratet M., O&#x2019;Keeffe S., Nwakeze C., Pauli-Behn F., Newberry K.M., Meadows S.K., et al. Intricate interplay between astrocytes and motor neurons in ALS. Proc. Natl. Acad. Sci. USA. 2013;110:E756&#x2013;E765. doi: 10.1073/pnas.1222361110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222361110</ArticleId><ArticleId IdType="pmc">PMC3581928</ArticleId><ArticleId IdType="pubmed">23388633</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Arrigo A., Colavito D., Pena-Altamira E., Fabris M., Dam M., Contestabile A., Leon A. Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: A role for wild-type superoxide dismutase 1 in sporadic disease? J. Mol. Neurosci. 2010;41:404&#x2013;415. doi: 10.1007/s12031-010-9332-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9332-2</ArticleId><ArticleId IdType="pubmed">20177826</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby J., Ning K., Ferraiuolo L., Heath P.R., Ismail A., Kuo S.W., Valori C.F., Cox L., Sharrack B., Wharton S.B., et al. Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain. 2011;134:506&#x2013;517. doi: 10.1093/brain/awq345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq345</ArticleId><ArticleId IdType="pmc">PMC3030763</ArticleId><ArticleId IdType="pubmed">21228060</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Ito H., Wate R., Ohnishi S., Nakano S., Kusaka H. Altered distributions of nucleocytoplasmic transport-related proteins in the spinal cord of a mouse model of amyotrophic lateral sclerosis. Acta Neuropathol. 2006;112:673&#x2013;680. doi: 10.1007/s00401-006-0130-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-006-0130-4</ArticleId><ArticleId IdType="pubmed">16957927</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y.M., Yamamoto M., Kobayashi Y., Yoshihara T., Liang Y., Terao S., Takeuchi H., Ishigaki S., Katsuno M., Adachi H., et al. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 2005;57:236&#x2013;251. doi: 10.1002/ana.20379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20379</ArticleId><ArticleId IdType="pubmed">15668976</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M.S., Hwang N.S., Lee J., Kim T.K., Leong K., Shamblott M.J., Gearhart J., Elisseeff J. Musculoskeletal differentiation of cells derived from human embryonic germ cells. Stem Cells. 2005;23:113&#x2013;123. doi: 10.1634/stemcells.2004-0110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/stemcells.2004-0110</ArticleId><ArticleId IdType="pubmed">15625128</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumucio J.P., Sugg K.B., Mendias C.L. TGF-beta superfamily signaling in muscle and tendon adaptation to resistance exercise. Exerc. Sport Sci. Rev. 2015;43:93&#x2013;99. doi: 10.1249/JES.0000000000000041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/JES.0000000000000041</ArticleId><ArticleId IdType="pmc">PMC4369187</ArticleId><ArticleId IdType="pubmed">25607281</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Black B.L., Derynck R. TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev. 2001;15:2950&#x2013;2966. doi: 10.1101/gad.925901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.925901</ArticleId><ArticleId IdType="pmc">PMC312830</ArticleId><ArticleId IdType="pubmed">11711431</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendias C.L., Gumucio J.P., Davis M.E., Bromley C.W., Davis C.S., Brooks S.V. Transforming growth factor-beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis. Muscle Nerve. 2012;45:55&#x2013;59. doi: 10.1002/mus.22232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22232</ArticleId><ArticleId IdType="pmc">PMC3245632</ArticleId><ArticleId IdType="pubmed">22190307</ArticleId></ArticleIdList></Reference><Reference><Citation>Narola J., Pandey S.N., Glick A., Chen Y.W. Conditional expression of TGF-beta1 in skeletal muscles causes endomysial fibrosis and myofibers atrophy. PLoS ONE. 2013;8:e79356. doi: 10.1371/journal.pone.0079356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079356</ArticleId><ArticleId IdType="pmc">PMC3828351</ArticleId><ArticleId IdType="pubmed">24244485</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.L., Colgan T.D., Walton K.L., Gregorevic P., Harrison C.A. The TGF-beta signalling network in muscle development, adaptation and disease. Adv. Exp. Med. Biol. 2016;900:97&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">27003398</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M., Adachi H., Minamiyama M., Waza M., Doi H., Kondo N., Mizoguchi H., Nitta A., Yamada K., Banno H., et al. Disrupted transforming growth Factor-{beta} signaling in spinal and bulbar muscular atrophy. J. Neurosci. 2010;30:5702&#x2013;5712. doi: 10.1523/JNEUROSCI.0388-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0388-10.2010</ArticleId><ArticleId IdType="pmc">PMC6632356</ArticleId><ArticleId IdType="pubmed">20410122</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P., Polanco M.J., Cristofani R., Cicardi M.E., Meroni M., Galbiati M., Piccolella M., Messi E., Giorgetti E., Lieberman A.P., et al. Aberrant autophagic response in the muscle of a knock-in mouse model of spinal and bulbar muscular atrophy. Sci. Rep. 2015;5:15174. doi: 10.1038/srep15174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15174</ArticleId><ArticleId IdType="pmc">PMC4614888</ArticleId><ArticleId IdType="pubmed">26490709</ArticleId></ArticleIdList></Reference><Reference><Citation>Burks T.N., Cohn R.D. Role of TGF-beta signaling in inherited and acquired myopathies. Skelet. Muscle. 2011;1:19. doi: 10.1186/2044-5040-1-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2044-5040-1-19</ArticleId><ArticleId IdType="pmc">PMC3156642</ArticleId><ArticleId IdType="pubmed">21798096</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohn R.D., van Erp C., Habashi J.P., Soleimani A.A., Klein E.C., Lisi M.T., Gamradt M., Ap Rhys C.M., Holm T.M., Loeys B.L., et al. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat. Med. 2007;13:204&#x2013;210. doi: 10.1038/nm1536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1536</ArticleId><ArticleId IdType="pmc">PMC3138130</ArticleId><ArticleId IdType="pubmed">17237794</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal T., Polanco M.J., Scaramuzzino C., Rocchi A., Milioto C., Emionite L., Ognio E., Sambataro F., Galbiati M., Poletti A., et al. Androgens affect muscle, motor neuron, and survival in a mouse model of SOD1-related amyotrophic lateral sclerosis. Neurobiol. Aging. 2014;35:1929&#x2013;1938. doi: 10.1016/j.neurobiolaging.2014.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.02.004</ArticleId><ArticleId IdType="pubmed">24630363</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P.F., Dubourg O., de Tapia M., di Scala F., Dupuis L., Lenglet T., Bruneteau G., Salachas F., Lacomblez L., Corvol J.C., et al. Muscle gene expression is a marker of amyotrophic lateral sclerosis severity. Neurodegener. Dis. 2012;9:38&#x2013;52. doi: 10.1159/000329723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000329723</ArticleId><ArticleId IdType="pubmed">21934272</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y., Kim S., Cui X., Zheng L., Oh S.J., Anderson T., AlSharabati M., Kazamel M., Volpicelli-Daley L., Bamman M.M., et al. Transforming growth factor beta (TGF-beta) is a muscle biomarker of disease progression in ALS and correlates with smad expression. PLoS ONE. 2015;10:e0138425. doi: 10.1371/journal.pone.0138425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0138425</ArticleId><ArticleId IdType="pmc">PMC4574401</ArticleId><ArticleId IdType="pubmed">26375954</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y., Cui X., Kim S., Wians R., Sorge R., Oh S.J., Kwan T., AlSharabati M., Lu L., Claussen G., et al. Smads as muscle biomarkers in amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 2014;1:778&#x2013;787. doi: 10.1002/acn3.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.117</ArticleId><ArticleId IdType="pmc">PMC4241805</ArticleId><ArticleId IdType="pubmed">25493269</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters S., Zitzelsperger E., Kuespert S., Iberl S., Heydn R., Johannesen S., Petri S., Aigner L., Thal D.R., Hermann A., et al. The TGF-beta System As a Potential Pathogenic Player in Disease Modulation of Amyotrophic Lateral Sclerosis. Front. Neurol. 2017;8:669. doi: 10.3389/fneur.2017.00669.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00669</ArticleId><ArticleId IdType="pmc">PMC5736544</ArticleId><ArticleId IdType="pubmed">29326641</ArticleId></ArticleIdList></Reference><Reference><Citation>Saris C.G., Groen E.J., van Vught P.W., van Es M.A., Blauw H.M., Veldink J.H., van den Berg L.H. Gene expression profile of SOD1-G93A mouse spinal cord, blood and muscle. Amyotroph. Lateral Scler. Front. Degener. 2013;14:190&#x2013;198. doi: 10.3109/21678421.2012.749914.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2012.749914</ArticleId><ArticleId IdType="pubmed">23298163</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M., Ferri A., Carri M.T. Amyotrophic lateral sclerosis: From current developments in the laboratory to clinical implications. Antioxid Redox Signal. 2008;10:405&#x2013;443. doi: 10.1089/ars.2007.1760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2007.1760</ArticleId><ArticleId IdType="pubmed">18370853</ArticleId></ArticleIdList></Reference><Reference><Citation>Sau D., De Biasi S., Vitellaro-Zuccarello L., Riso P., Guarnieri S., Porrini M., Simeoni S., Crippa V., Onesto E., Palazzolo I., et al. Mutation of SOD1 in ALS: A gain of a loss of function. Hum. Mol. Genet. 2007;16:1604&#x2013;1618. doi: 10.1093/hmg/ddm110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm110</ArticleId><ArticleId IdType="pubmed">17504823</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcellos-Hoff M.H., Dix T.A. Redox-mediated activation of latent transforming growth factor-beta 1. Mol. Endocrinol. 1996;10:1077&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">8885242</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez D., Contreras O., Rebolledo D.L., Espinoza J.P., van Zundert B., Brandan E. ALS skeletal muscle shows enhanced TGF-beta signaling, fibrosis and induction of fibro/adipogenic progenitor markers. PLoS ONE. 2017;12:e0177649. doi: 10.1371/journal.pone.0177649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177649</ArticleId><ArticleId IdType="pmc">PMC5433732</ArticleId><ArticleId IdType="pubmed">28520806</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsujihata M., Hazama R., Yoshimura T., Satoh A., Mori M., Nagataki S. The motor end-plate fine structure and ultrastructural localization of acetylcholine receptors in amyotrophic lateral sclerosis. Muscle Nerve. 1984;7:243&#x2013;249. doi: 10.1002/mus.880070310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880070310</ArticleId><ArticleId IdType="pubmed">6708970</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney E.B., de Winter F., Verhaagen J. ALS as a distal axonopathy: Molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front. Neurosci. 2014;8:252. doi: 10.3389/fnins.2014.00252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappello V., Francolini M. Neuromuscular junction dismantling in amyotrophic lateral sclerosis. Int. J. Mol. Sci. 2017;18:2092. doi: 10.3390/ijms18102092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18102092</ArticleId><ArticleId IdType="pmc">PMC5666774</ArticleId><ArticleId IdType="pubmed">28972545</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z., Ko C.P. Schwann cells promote synaptogenesis at the neuromuscular junction via transforming growth factor-beta1. J. Neurosci. 2008;28:9599&#x2013;9609. doi: 10.1523/JNEUROSCI.2589-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2589-08.2008</ArticleId><ArticleId IdType="pmc">PMC3844879</ArticleId><ArticleId IdType="pubmed">18815246</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco D.I., Seburn K.L., Pinter M.J. Altered terminal Schwann cell morphology precedes denervation in SOD1 mice. Exp. Neurol. 2016;275:172&#x2013;181. doi: 10.1016/j.expneurol.2015.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.014</ArticleId><ArticleId IdType="pmc">PMC4768763</ArticleId><ArticleId IdType="pubmed">26416261</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science. 2009;326:1549&#x2013;1554. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Taetzsch T., Tenga M.J., Valdez G. Muscle fibers secrete FGFBP1 to slow degeneration of neuromuscular synapses during aging and progression of ALS. J. Neurosci. 2017;37:70&#x2013;82. doi: 10.1523/JNEUROSCI.2992-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2992-16.2016</ArticleId><ArticleId IdType="pmc">PMC5214636</ArticleId><ArticleId IdType="pubmed">28053031</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennetta G., Hiesinger P.R., Fabian-Fine R., Meinertzhagen I.A., Bellen H.J. Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner. Neuron. 2002;35:291&#x2013;306. doi: 10.1016/S0896-6273(02)00769-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00769-9</ArticleId><ArticleId IdType="pubmed">12160747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratnaparkhi A., Lawless G.M., Schweizer F.E., Golshani P., Jackson G.R. A Drosophila model of ALS: Human ALS-associated mutation in VAP33A suggests a dominant negative mechanism. PLoS ONE. 2008;3:e2334. doi: 10.1371/journal.pone.0002334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002334</ArticleId><ArticleId IdType="pmc">PMC2390852</ArticleId><ArticleId IdType="pubmed">18523548</ArticleId></ArticleIdList></Reference><Reference><Citation>Day W.A., Koishi K., Nukuda H., McLennan I.S. Transforming growth factor-beta 2 causes an acute improvement in the motor performance of transgenic ALS mice. Neurobiol. Dis. 2005;19:323&#x2013;330. doi: 10.1016/j.nbd.2005.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.01.010</ArticleId><ArticleId IdType="pubmed">15837588</ArticleId></ArticleIdList></Reference><Reference><Citation>Holzbaur E.L., Howland D.S., Weber N., Wallace K., She Y., Kwak S., Tchistiakova L.A., Murphy E., Hinson J., Karim R., et al. Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiol. Dis. 2006;23:697&#x2013;707. doi: 10.1016/j.nbd.2006.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.05.009</ArticleId><ArticleId IdType="pubmed">16837207</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison B.M., Lachey J.L., Warsing L.C., Ting B.L., Pullen A.E., Underwood K.W., Kumar R., Sako D., Grinberg A., Wong V., et al. A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 2009;217:258&#x2013;268. doi: 10.1016/j.expneurol.2009.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2009.02.017</ArticleId><ArticleId IdType="pubmed">19285073</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>